Lawrence Mertz

Director Técnico/Científico/I+D en ACCELERATE DIAGNOSTICS, INC. .

64 años

Health Technology

Consumer Services

Perfil

Lawrence Mertz currently works at Accelerate Diagnostics, Inc., as Chief Technology Officer from 2022.
Dr. Mertz also formerly worked at Biora Therapeutics, Inc., as Vice President-Research & Development, Engineering and Meridian Bioscience, Inc., as SVP-Clinical Operations, Research & Development from 2018 to 2021.
Dr. Mertz received his undergraduate degree and doctorate degree from State University of New York at Buffalo.

Cargos activos de Lawrence Mertz

Empresas	Cargo	Inicio
ACCELERATE DIAGNOSTICS, INC.	Director Técnico/Científico/I+D	01/05/2021

Todos los cargos activos de Lawrence Mertz

Antiguos cargos conocidos de Lawrence Mertz.

Empresas	Cargo	Fin
MERIDIAN BIOSCIENCE, INC.	Director Técnico/Científico/I+D	01/04/2021
BIORA THERAPEUTICS, INC.	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Lawrence Mertz.

Formación de Lawrence Mertz.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Lawrence Mertz.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Meridian Bioscience, Inc. Meridian Bioscience, Inc. Medical SpecialtiesHealth Technology Operates as a life science company that develops, manufactures, markets and distributes diagnostic products	Health Technology
Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions	Health Technology
State University of New York at Buffalo State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Biora Therapeutics, Inc. Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases	Health Technology